Granite Fo LLC Vertex Pharmaceuticals Inc Transaction History

Granite Fo LLC

$177 Billion
Q3 2024

A detailed history of Granite Fo LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Granite Fo LLC holds 8 shares of VRTX stock, worth $3,807. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$3,807

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Oct 18, 2024	BUY	$460.0 - $505.78 $3,680 - $4,046	8 New	8 $3.72 Million
Q1 2024 Sep 05, 2024	BUY	$407.69 - $446.08 $3,261 - $3,568	8 New	8 $3.92 Million

Others Institutions Holding VRTX

# of Institutions

1,717

Shares Held

226M

Call Options Held

1.21M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$12.7 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$10.9 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.1 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.58 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.06 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Fo LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Fo LLC with notifications on news.

Account